156 related articles for article (PubMed ID: 10392463)
1. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy.
Adams K; Rainbow AJ; Wilson BC; Singh G
J Photochem Photobiol B; 1999 Apr; 49(2-3):136-41. PubMed ID: 10392463
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy.
Wilson BC; Olivo M; Singh G
Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance to photofrin-mediated photodynamic therapy and UV light and recovery from photodynamic therapy damage in Rif-8A mouse fibrosarcoma cells measured using viral capacity.
DiProspero L; Singh G; Wilson BC; Rainbow AJ
J Photochem Photobiol B; 1997 Apr; 38(2-3):143-51. PubMed ID: 9203375
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial alterations in photodynamic therapy-resistant cells.
Sharkey SM; Wilson BC; Moorehead R; Singh G
Cancer Res; 1993 Oct; 53(20):4994-9. PubMed ID: 8402690
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
6. Induction of Hsp60 by Photofrin-mediated photodynamic therapy.
Hanlon JG; Adams K; Rainbow AJ; Gupta RS; Singh G
J Photochem Photobiol B; 2001 Nov; 64(1):55-61. PubMed ID: 11705730
[TBL] [Abstract][Full Text] [Related]
7. Resistance to photodynamic therapy in radiation induced fibrosarcoma-1 and Chinese hamster ovary-multi-drug resistant. Cells in vitro.
Singh G; Wilson BC; Sharkey SM; Browman GP; Deschamps P
Photochem Photobiol; 1991 Aug; 54(2):307-12. PubMed ID: 1838198
[TBL] [Abstract][Full Text] [Related]
8. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
Henderson BW; Fingar VH
Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy.
Moorehead RA; Armstrong SG; Wilson BC; Singh G
Cancer Res; 1994 May; 54(10):2556-9. PubMed ID: 7909492
[TBL] [Abstract][Full Text] [Related]
11. Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy.
Luna MC; Gomer CJ
Cancer Res; 1991 Aug; 51(16):4243-9. PubMed ID: 1831066
[TBL] [Abstract][Full Text] [Related]
12. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
13. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
Waldow SM; Henderson BW; Dougherty TJ
Lasers Surg Med; 1987; 7(1):12-22. PubMed ID: 2952850
[TBL] [Abstract][Full Text] [Related]
17. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
18.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
19. In vivo relaxation time measurements on a murine tumor model--prolongation of T1 after photodynamic therapy.
Liu YH; Hawk RM; Ramaprasad S
Magn Reson Imaging; 1995; 13(2):251-8. PubMed ID: 7739367
[TBL] [Abstract][Full Text] [Related]
20. Investigation of cross-resistance to a range of photosensitizers, hyperthermia and UV light in two radiation-induced fibrosarcoma cell strains resistant to photodynamic therapy in vitro.
Mayhew S; Vernon DI; Schofield J; Griffiths J; Brown SB
Photochem Photobiol; 2001 Jan; 73(1):39-46. PubMed ID: 11202364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
